Medigus Ltd. announced key appointments to its global commercial team. Key appointments include: Tom Dempsey, new VP/GM United States, brings a diverse functional experience, including 19 years leading start-ups through established medical device companies including Boston Scientific and Endogastric Solutions (EGS), where he was VP, Commercialization. Mr. Dempsey was previously CEO of Medical Diagnostic Technologies and Peak Heart; Sheila Stevens, PhD, Sr. Director Regulatory and Clinical, has an extensive track record within Clinical and Regulatory Affairs including positions at Clear Catheter Systems, BaroSense Inc., Apneon, and Kyphon; Lori Saper, Sr. Director Professional Education, has vast experience working as an educator in the Operating Room (OR) and ICU environment with surgical and clinical teams. Ms. Saper brings over 20 years of experience in Medical and Clinical Trial Management in Europe and the U.S including positions at BioVentryx, Pioneer Surgical Technology, and Kyphon; Milena Ridl, new VP Europe, brings strong commercial and market development experience throughout Europe, including leadership roles at Kyphon, MiMedx and SpineAlign. These new team members join the company's established operating and R&D team based in Omer, Israel.

The company also announced that it has established a subsidiary office in the San Francisco, California Bay Area to drive regional adoption for MUSE in the U.S.